Amarantus Founders Gerald and Dr. John Commissiong Selected as Black Money's "50 Most Important African-Americans in Technology"
Amarantus In-Licenses Levadopa-Induced Dyskinesia Phase 2b-Ready Eltoprazine From PGI Drug Discovery
Gerald Commissiong, CEO of Amarantus to Participate in Twitter Chat, "The Human Brain"
Amarantus to Present at Biotech and Healthcare Conferences During JP Morgan Week in San Francisco
Amarantus Licenses MANF-Related Wolfram's and Diabetes Therapeutic and Diagnostic Intellectual Property From University of Massachusetts Medical School
Amarantus and Brewer Sports Announce ONE MIND for Research at 2nd #C4CT Concussion Awareness Summit Prior to Super Bowl XLVIII at United Nations
Amarantus Obtains Exclusive Option to License University of Miami Bascom Palmer Eye Institute's Intellectual Property for the Treatment of Retinal Diseases Using MANF and CDNF
Amarantus BioScience to Present at the LD Micro Sixth Annual Conference on December 3, 2013